Lifestyle Delivery Systems Inc. announced that on April 26, 2016, the company appointed Dr. John Sanderson, MD as its Chief Science Officer. Dr. Sanderson's main objectives will be to work in conjunction with researchers to advance the development of the company's CannaStrips technology as well as to create protocols necessary for the much anticipated clinical trials. In addition, Dr. Sanderson will work on composition of the white papers, following the results of the clinical trials, and secure patents for the CannaStrips technology.